Quantum Biopharma (QNTM) Receivables - Other (2019 - 2025)

Quantum Biopharma has disclosed Receivables - Other across 6 years of filings, most recently posting $231053.0 for Q4 2025.

• Receivables - Other for Q4 2025 came in at $231053.0, down 38.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $231053.0 (down 38.33% YoY), and the FY2025 annual result was $231053.0, down 38.33% from the prior year.
• Receivables - Other came in at $231053.0 for Q4 2025 at Quantum Biopharma, down from $2.9 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $7.4 million in Q1 2023 to a low of $228764.0 in Q4 2023.
• The 4-year median for Receivables - Other is $3.0 million (2025), against an average of $3.4 million.
• Across the five-year window, Receivables - Other jumped 151.45% in 2023 and plunged 59.07% in 2025, its largest moves.
• Quantum Biopharma's Receivables - Other stood at $374377.0 in 2022, then slumped by 38.89% to $228764.0 in 2023, then soared by 63.78% to $374678.0 in 2024, then slumped by 38.33% to $231053.0 in 2025.
• The last three Receivables - Other figures came in at $231053.0 (Q4 2025), $2.9 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.